ACTRN12616000877482招募中未知
A Prospective Cohort Study to Assess Body Composition as a Predictor of Outcomes in Pancreatic Ductal Adenocarcinoma
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •-Pancreatic ductal adenocarcinoma
- •-Diagnosed with pancreatic cancer within the last month
排除标准
- •Neuromuscular disease
研究者
相似试验
尚未招募
不适用
Effect of obesity and diabetes on treatment and outcomes in newly diagnosed breast cancerBreast cancer chemotherapy dosingCancer - BreastACTRN12610000196044niversity of Queensland128
尚未招募
不适用
Body Composition Validation StudyBody Compositionthe composition of the human bodyNL-OMON35857Philips Research60
已完成
不适用
A study to investigate the body composition using CT scan images in patients visiting a primary care hospital.JPRN-UMIN000032577agoya University Graduate School of Medicine1,000
进行中（未招募）
不适用
A Prospective Cohort Study Evaluating the Incidence of NephrogenicSystemic Fibrosis in Patients with Stages 3 to 5 Chronic Kidney DiseaseUndergoing MRI with the Injection of ProHance - Evaluation of the Incidence of NSF Following ProHance InjectioEUCTR2007-003589-16-FRBracco Imaging S.p.A.1,000
进行中（未招募）
不适用
A PROSPECTIVE COHORT STUDY EVALUATING THE INCIDENCE OF NEPHROGENIC SYSTEMIC FIBROSIS IN PATIENTS WITH STAGES 3 TO 5 CHRONIC KIDNEY DISEASE UNDERGOING MRI WITH THE INJECTION OF PROHANCE - Evaluation of the Risk of NSF Following ProHance InjectioSafety of Contrast enhanced MRI diagnoses in patients suffering from some chronic kidney disease stage 3 (cohort 1) or stage 4 to 5 (cohort 2)MedDRA version: 9.1Level: LLTClassification code 10029820MedDRA version: 9.1Level: SOCClassification code 10038359EUCTR2007-003589-16-ITBRACCO IMAGING1,000